Business Description
Organogenesis Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US68621F1021
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.87 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | 3.31 | |||||
Interest Coverage | 5.72 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.33 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.4 | |||||
3-Year EBITDA Growth Rate | -6.7 | |||||
3-Year EPS without NRI Growth Rate | -32.5 | |||||
3-Year Book Growth Rate | 24.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.84 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.71 | |||||
9-Day RSI | 36.48 | |||||
14-Day RSI | 38.44 | |||||
6-1 Month Momentum % | 26.91 | |||||
12-1 Month Momentum % | 33.49 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.8 | |||||
Quick Ratio | 2.44 | |||||
Cash Ratio | 1.29 | |||||
Days Inventory | 90.39 | |||||
Days Sales Outstanding | 75.23 | |||||
Days Payable | 101.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 1.81 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.42 | |||||
Operating Margin % | 2.89 | |||||
Net Margin % | 1.14 | |||||
FCF Margin % | 1.51 | |||||
ROE % | 1.82 | |||||
ROA % | 1.09 | |||||
ROIC % | 1.99 | |||||
ROC (Joel Greenblatt) % | 5.71 | |||||
ROCE % | 3.34 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 67.78 | |||||
PE Ratio without NRI | 67.78 | |||||
PS Ratio | 0.73 | |||||
PB Ratio | 1.15 | |||||
Price-to-Tangible-Book | 1.37 | |||||
Price-to-Free-Cash-Flow | 48.68 | |||||
Price-to-Operating-Cash-Flow | 10.33 | |||||
EV-to-EBIT | 26.42 | |||||
EV-to-Forward-EBIT | 5.05 | |||||
EV-to-EBITDA | 9.22 | |||||
EV-to-Forward-EBITDA | 4.15 | |||||
EV-to-Revenue | 0.77 | |||||
EV-to-Forward-Revenue | 0.78 | |||||
EV-to-FCF | 50.72 | |||||
Price-to-Projected-FCF | 3.7 | |||||
Price-to-Graham-Number | 2.03 | |||||
Price-to-Net-Current-Asset-Value | 7.39 | |||||
Earnings Yield (Greenblatt) % | 3.79 | |||||
FCF Yield % | 2.03 |